Shilpa Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SHILPA
SHILPA has fifteen approved drugs.
There are five US patents protecting SHILPA drugs. There are two tentative approvals on SHILPA drugs.
Summary for Shilpa
| US Patents: | 5 |
| Tradenames: | 13 |
| Ingredients: | 13 |
| NDAs: | 15 |
| Patent Litigation for Shilpa: | See patent lawsuits for Shilpa |
Drugs and US Patents for Shilpa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shilpa | APREMILAST | apremilast | TABLET;ORAL | 211774-002 | Apr 7, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Shilpa | VARENICLINE TARTRATE | varenicline tartrate | TABLET;ORAL | 216615-002 | Apr 8, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Shilpa | DOCETAXEL | docetaxel | INJECTABLE;INJECTION | 210327-002 | May 16, 2019 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Shilpa Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Taiwan | I511726 | ⤷ Start Trial |
| Mexico | 2015003824 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2016151365 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Shilpa Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1746976 | 300885 | Netherlands | ⤷ Start Trial | PRODUCT NAME: IRINOTECANSUCROSOFAATZOUT; REGISTRATION NO/DATE: EU/1/16/1130 20161018 |
| 2962690 | LUC00125 | Luxembourg | ⤷ Start Trial | PRODUCT NAME: APREMILAST, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; AUTHORISATION NUMBER AND DATE: EU/1/14/981 20150116 |
| 2962690 | SPC/GB19/045 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: APREMILAST, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: UK EU/1/14/981/001(NI) 20150116; UK EU/1/14/981/002(NI) 20150116; UK EU/1/14/981/003(NI) 20150116; UK PLGB 50412/0006 20150116; UK PLGB 50412/0007 20150116 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
